Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Laboratory characterization of invasive Haemophilus influenzae isolates from Nunavut, Canada, 2000-2012.

Tsang RS, Li YA, Mullen A, Baikie M, Whyte K, Shuel M, Tyrrell G, Rotondo JA, Desai S, Spika J.

Int J Circumpolar Health. 2016 Jan 12;75:29798. doi: 10.3402/ijch.v75.29798. eCollection 2016.

2.

Immunization as a tool to combat antimicrobial resistance.

Spika J, Rud EW.

Can Commun Dis Rep. 2015 Nov 19;41(Suppl 5):7-10. eCollection 2015 Nov 19.

3.

Next Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada.

Twine SM, Fulton KM, Spika J, Ouellette M, Raven JF, Conlan JW, Krishnan L, Barreto L, Richards JC.

Hum Vaccin Immunother. 2015;11(12):2923-30. doi: 10.1080/21645515.2015.1083663.

4.

Incorporating economic evaluation into immunization decision making in Canada: a workshop.

Langley JM, Krahn M, Husereau D, Spika J, Fisman DN, Chit A, Van Exan R.

Expert Rev Vaccines. 2014 Nov;13(11):1291-6. doi: 10.1586/14760584.2014.939637. Epub 2014 Jul 23. No abstract available.

5.

Supplementary immunization activities to achieve measles elimination: experience of the European Region.

Khetsuriani N, Deshevoi S, Goel A, Spika J, Martin R, Emiroglu N.

J Infect Dis. 2011 Jul;204 Suppl 1:S343-52. doi: 10.1093/infdis/jir074.

PMID:
21666183
6.

Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009.

Helferty M, Vachon J, Tarasuk J, Rodin R, Spika J, Pelletier L.

CMAJ. 2010 Dec 14;182(18):1981-7. doi: 10.1503/cmaj.100746. Epub 2010 Nov 8.

7.

Enhanced surveillance for measles in low-incidence territories of the Russian Federation: defining a rate for suspected case investigation.

Tikhonova NT, Bichurina MA, Gerasimova AG, Zvirkun OV, Vladimerova NP, Mamaeva T, Lipskaya G, Elsaadany S, Spika JS.

Epidemiol Infect. 2011 Feb;139(2):239-46. doi: 10.1017/S0950268810000658. Epub 2010 Apr 6.

PMID:
20367894
8.

Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza.

Campbell A, Rodin R, Kropp R, Mao Y, Hong Z, Vachon J, Spika J, Pelletier L.

CMAJ. 2010 Mar 9;182(4):349-55. doi: 10.1503/cmaj.091823. Epub 2010 Feb 16.

9.

Pandemic influenza (H1N1): our Canadian response.

Spika JS, Butler-Jones D.

Can J Public Health. 2009 Sep-Oct;100(5):337-9.

PMID:
19994732
10.

Increase in poliomyelitis cases in Nigeria.

Desai S, Pelletier L, Garner M, Spika J.

CMAJ. 2008 Oct 21;179(9):930. doi: 10.1503/cmaj.081265. Epub 2008 Oct 2. Review. No abstract available.

11.

Nationwide measles epidemic in Ukraine: the effect of low vaccine effectiveness.

Velicko I, Müller LL, Pebody R, Gergonne B, Aidyralieva C, Kostiuchenko N, Spika JS.

Vaccine. 2008 Dec 9;26(52):6980-5. doi: 10.1016/j.vaccine.2008.09.012. Epub 2008 Sep 19.

PMID:
18805455
12.

Measles elimination 2010 target: the need to meet the specific risk group.

Spika J.

Euro Surveill. 2006;11(10):202. No abstract available.

PMID:
17130660
13.

Measles outbreak in the Ukraine, 2005-2006.

Spika JS, Aidyralieva C, Mukharskaya L, Kostyuchenko NN, Mulders M, Lipskaya G, Emiroglu N.

Euro Surveill. 2006 Mar 9;11(3):E060309.1. No abstract available.

PMID:
16804226
14.

Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee On Research Related To Measles and Rubella Vaccines and Vaccination, June 2004.

Best JM, Castillo-Solorzano C, Spika JS, Icenogle J, Glasser JW, Gay NJ, Andrus J, Arvin AM.

J Infect Dis. 2005 Dec 1;192(11):1890-7. Epub 2005 Oct 31.

PMID:
16267759
15.

Preventing congenital rubella infection in the European Region of WHO: 2010 target.

Spika JS, Hanon FX, Wassilak S, Pebody R, Emiroglu N.

Euro Surveill. 2004 Apr;9(4):4-5.

PMID:
15192255
16.

Preventing congenital rubella infection in the European Region of WHO: 2010 target.

Spika JS, Hanon FX, Wassilak S, Pebody RG, Emiroglu N.

Euro Surveill. 2004 Apr;9(4):3-4. doi: 10.2807/esm.09.04.00455-en.

PMID:
29183454
17.

Measles and rubella in the World Health Organization European region: diversity creates challenges.

Spika JS, Wassilak S, Pebody R, Lipskaya G, Deshevoi S, Guris D, Emiroglu N.

J Infect Dis. 2003 May 15;187 Suppl 1:S191-7. Review.

PMID:
12721913
18.

Pertussis is a frequent cause of prolonged cough illness in adults and adolescents.

Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B; Sentinel Health Unit Surveillance System Pertussis Working Group.

Clin Infect Dis. 2001 Jun 15;32(12):1691-7. Epub 2001 May 21.

PMID:
11360208
19.

Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. Sentinel Health Unit Surveillance System Site Coordinators.

Tyrrell GJ, Senzilet LD, Spika JS, Kertesz DA, Alagaratnam M, Lovgren M, Talbot JA.

J Infect Dis. 2000 Jul;182(1):168-73. Epub 2000 Jun 29.

PMID:
10882594
20.

Pneumococcal immunization and public health: the Canadian experience.

Spika JS, Keresz D, Deeks S, Talbot JA.

Vaccine. 1999 Jul 30;17 Suppl 1:S105-8. Review.

PMID:
10471193
21.

A Canadian multicentre case-control study of sporadic Escherichia coli 0157:H7 infection.

Holton D, Wilson J, Ellis A, Haldane D, April N, Grimsrud K, Friesen B, Spika J.

Can J Infect Dis. 1999 Mar;10(2):117-21.

22.

Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group.

Deeks SL, Palacio R, Ruvinsky R, Kertesz DA, Hortal M, Rossi A, Spika JS, Di Fabio JL.

Pediatrics. 1999 Feb;103(2):409-13.

PMID:
9925833
23.

Protecting against invasive pneumococcal disease: be wise--immunize!

Squires SG, Spika JS.

CMAJ. 1998 Oct 6;159(7):826-7. No abstract available.

24.

[Pneumococcal infection and anti-pneumococcal vaccination programs in Canada].

Spika JS, Kertesz D, Deeks S, Talbot J.

Presse Med. 1998 May;27 Suppl 1:39-42. French. No abstract available.

PMID:
9779040
25.

Salmonella typhimurium DT104: a virulent and drug-resistant pathogen.

Poppe C, Smart N, Khakhria R, Johnson W, Spika J, Prescott J.

Can Vet J. 1998 Sep;39(9):559-65. Review.

26.

Effectiveness of pneumococcal vaccine.

Butler JC, Spika JS, Nichol KL, Shapiro ED, Breinan RF.

Lancet. 1998 Jun 27;351(9120):1961; author reply 1962. No abstract available.

PMID:
9654289
27.

Invasive Streptococcus pneumoniae infection in Latin American children: results of the Pan American Health Organization Surveillance Study.

Kertesz DA, Di Fabio JL, de Cunto Brandileone MC, Castañeda E, Echániz-Aviles G, Heitmann I, Homma A, Hortal M, Lovgren M, Ruvinsky RO, Talbot JA, Weekes J, Spika JS.

Clin Infect Dis. 1998 Jun;26(6):1355-61.

PMID:
9636862
28.

Risk factors for infection with verocytotoxigenic Escherichia coli in cattle on Ontario dairy farms.

Wilson JB, Renwick SA, Clarke RC, Rahn K, Alves D, Johnson RP, Ellis AG, McEwen SA, Karmali MA, Lior H, Spika J.

Prev Vet Med. 1998 Feb 27;34(2-3):227-36.

PMID:
9604270
29.

Verocytotoxigenic Escherichia coli infection in dairy farm families.

Wilson J, Spika J, Clarke R, McEwen S, Johnson R, Rahn K, Renwick S, Karmali M, Lior H, Alves D, Gyles C, Sandhu K.

Can Commun Dis Rep. 1998 Feb 1;24(3):17-20. English, French. No abstract available.

30.

Follow-up study of verocytotoxigenic Escherichia coli infection in dairy farm families.

Rahn K, Renwick SA, Johnson RP, Wilson JB, Clarke RC, Alves D, McEwen SA, Lior H, Spika J.

J Infect Dis. 1998 Apr;177(4):1139-40. No abstract available.

PMID:
9535003
31.
32.

Persistence of Escherichia coli O157:H7 in dairy cattle and the dairy farm environment.

Rahn K, Renwick SA, Johnson RP, Wilson JB, Clarke RC, Alves D, McEwen S, Lior H, Spika J.

Epidemiol Infect. 1997 Oct;119(2):251-9.

33.

Canadian Perspectives on Verocytotoxin-Producing Escherichia coli Infection .

Wilson JB, Johnson RP, Clarke RC, Rahn K, Renwick SA, Alves D, Karmali MA, Michel P, Orrbine E, Spika JS.

J Food Prot. 1997 Nov;60(11):1451-1453. doi: 10.4315/0362-028X-60.11.1451.

PMID:
31207770
34.

Outbreak of viral gastroenteritis due to a contaminated well. International consequences.

Beller M, Ellis A, Lee SH, Drebot MA, Jenkerson SA, Funk E, Sobsey MD, Simmons OD 3rd, Monroe SS, Ando T, Noel J, Petric M, Middaugh JP, Spika JS.

JAMA. 1997 Aug 20;278(7):563-8.

PMID:
9268277
35.

Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes.

Troy CJ, Peeling RW, Ellis AG, Hockin JC, Bennett DA, Murphy MR, Spika JS.

JAMA. 1997 Apr 16;277(15):1214-8. Erratum in: JAMA 1997 Jul 9;278(2):118.

PMID:
9103345
36.

Vero cytotoxigenic Escherichia coli infection in dairy farm families.

Wilson JB, Clarke RC, Renwick SA, Rahn K, Johnson RP, Karmali MA, Lior H, Alves D, Gyles CL, Sandhu KS, McEwen SA, Spika JS.

J Infect Dis. 1996 Nov;174(5):1021-7.

PMID:
8896504
37.

Growing Concerns and Recent Outbreaks Involving Non-O157:H7 Serotypes of Verotoxigenic Escherichia coli.

Johnson RP, Clarke RC, Wilson JB, Read SC, Rahn K, Renwick SA, Sandhu KA, Alves D, Karmali MA, Lior H, McEwen SA, Spika JS, Gyles CL.

J Food Prot. 1996 Oct;59(10):1112-1122. doi: 10.4315/0362-028X-59.10.1112.

PMID:
31195470
38.

Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents.

Reymond D, Johnson RP, Karmali MA, Petric M, Winkler M, Johnson S, Rahn K, Renwick S, Wilson J, Clarke RC, Spika J.

J Clin Microbiol. 1996 Sep;34(9):2053-7.

40.

Surveillance for Streptococcus pneumoniae in Latin American children.

Kertesz DA, Spika JS, Talbot JA, Difabio JL.

Can J Infect Dis. 1996 Jan;7(1):21-3. No abstract available.

41.

Pneumococcal vaccine after 15 years of use. Another view.

Fedson DS, Shapiro ED, LaForce FM, Mufson MA, Musher DM, Spika JS, Breiman RF, Broome CV.

Arch Intern Med. 1994 Nov 28;154(22):2531-5. No abstract available.

PMID:
7979849
42.

Brucella abortus serology in cattle naturally infected with Escherichia coli O157.H7.

Johnson RP, Boag L, Anderson S, Holtslander R, Rahn K, Clarke RC, Renwick SA, Alves D, Wilson JB, Spika J.

Vet Rec. 1994 Oct 15;135(16):382-3. No abstract available.

PMID:
7831743
43.

Evidence of direct transmission of Escherichia coli O157:H7 infection between calves and a human--Ontario.

Renwick SA, Wilson JB, Clarke RC, Lior H, Borczyck A, Spika JS, Rahn K, McFadden K, Brouwer A, Copps A, et al.

Can Commun Dis Rep. 1994 May 15;20(9):73-5. English, French. No abstract available.

PMID:
8038753
44.

Use of multiple molecular subtyping techniques to investigate a Legionnaires' disease outbreak due to identical strains at two tourist lodges.

Mamolen M, Breiman RF, Barbaree JM, Gunn RA, Stone KM, Spika JS, Dennis DT, Mao SH, Vogt RL.

J Clin Microbiol. 1993 Oct;31(10):2584-8.

45.

Evidence of direct transmission of Escherichia coli O157:H7 infection between calves and a human.

Renwick SA, Wilson JB, Clarke RC, Lior H, Borczyk AA, Spika J, Rahn K, McFadden K, Brouwer A, Copps A, et al.

J Infect Dis. 1993 Sep;168(3):792-3. No abstract available.

PMID:
8354927
46.

The Hawaii pneumococcal disease initiative.

Campbell JF, Donohue MA, Nevin-Woods C, McBean AM, Pace NE, Williams WW, Spika JS.

Am J Public Health. 1993 Aug;83(8):1175-6. No abstract available.

PMID:
8342733
47.

Pneumococcal vaccination in a remote population of high-risk Alaska Natives.

Davidson M, Chamblee C, Campbell HG, Bulkow LR, Taylor GE, Lanier AP, Berner J, Spika JS, Williams WW, Middaugh JP.

Public Health Rep. 1993 Jul-Aug;108(4):439-46.

48.

Ground beef consumption in noncommercial settings is a risk factor for sporadic Escherichia coli O157:H7 infection in Canada.

Le Saux N, Spika JS, Friesen B, Johnson I, Melnychuck D, Anderson C, Dion R, Rahman M, Tostowarky W.

J Infect Dis. 1993 Feb;167(2):500-2. No abstract available.

PMID:
8421193
49.

Culture-confirmed pneumonia due to Chlamydia pneumoniae.

Campbell JF, Barnes RC, Kozarsky PE, Spika JS.

J Infect Dis. 1991 Aug;164(2):411-3.

PMID:
1856489
50.

Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group.

Spika JS, Facklam RR, Plikaytis BD, Oxtoby MJ.

J Infect Dis. 1991 Jun;163(6):1273-8.

PMID:
2037792

Supplemental Content

Support Center